Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | BCHE | P06276 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9820058 | 0.92 | MAPT (0.61) | MAPTTSHRHSD17B10MCHR1CYP3A4 | |
| SCHEMBL9820117 | 0.90 | ALDH1A1 (0.59) | MAPTTSHRHSD17B10MCHR1CYP3A4 | |
| Benzylsulfonylbenzene SCHEMBL780337 | 0.85 | TSHR (0.68) | MAPTTSHRHSD17B10CA9KMT2A | |
| Benzylsulfonylbenzene SCHEMBL1877584 | 0.83 | TSHR (0.66) | MAPTTSHRHSD17B10CA9KMT2A | |
| SCHEMBL18531405 | 0.82 | ALDH1A1 (0.52) | MAPTCYP3A4KMT2ARECQLALDH1A1 | |
| SCHEMBL26253885 | 0.82 | MAPT (0.55) | MAPTCYP3A4KMT2ARECQLALDH1A1 | |
| SCHEMBL10180226 | 0.82 | TSHR (0.61) | MAPTTSHRHSD17B10CA9ALDH1A1 | |
| SCHEMBL20002876 | 0.81 | ACHE (0.58) | MAPTCYP3A4BCHEACHEKMT2A | |
| SCHEMBL7669392 | 0.81 | ACHE (0.58) | MAPTCYP3A4BCHEACHEKMT2A | |
| SCHEMBL28887988 | 0.81 | MAPT (0.57) | MAPTTSHRHSD17B10CYP3A4ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111935052-B | Adaptive carrier and symbol combined synchronization method for QPSK signal | 哈尔滨工业大学 | 2022-03-08 | — | — | CN | claimed |
| CN-109761863-B | (E) - (2- (phenylsulfonyl) ethenyl) benzene and its derivative and synthetic method | 湘潭大学 | 2020-10-02 | — | — | CN | claimed |
| CN-109761863-A | (E)-(2-(phenyl sulfonyl) vinyl) benzene and its derivative and synthetic method | 湘潭大学 | 2019-05-17 | — | — | CN | claimed |
| CN-105017109-A | Method for compounding sulphone by directly conducting sulfonylation on alcohol | UNIV CHONGQING | 2015-11-04 | — | — | CN | claimed |
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | claimed |
| CN-117886723-A | Synthesis method of 2-chloro-4-methylsulfonyl benzoic acid | 辽宁龙田化工科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-117263832-A | Synthesis method of 2-chloro-4-methylsulfonyl benzoic acid | 辽宁龙田化工科技有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-11795144-B2 | Inhibitors of RAC1 and uses thereof for treating cancers | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2023-10-24 | — | — | US | disclosed |
| US-20230288610-A1 | WAVELENGTH SELECTIVE ABSORPTION FILTER AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| CN-111935052-B | Adaptive carrier and symbol combined synchronization method for QPSK signal | 哈尔滨工业大学 | 2022-03-08 | — | — | CN | disclosed |
| WO-2021127337-A1 | TRPML MODULATORS | CASMA THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| CN-109761863-B | (E) - (2- (phenylsulfonyl) ethenyl) benzene and its derivative and synthetic method | 湘潭大学 | 2020-10-02 | — | — | CN | disclosed |
| EP-0602914-A1 | Ink compositions for ink jet printing | XEROX CORPORATION (US) | 1994-06-22 | — | — | EP | disclosed |
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0182299-B1 | A CURABLE FLUOROELASTOMER COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-04-03 | — | — | EP | disclosed |
| US-4748208-A | FLUOROPOLYMER, BIS/PHOSPHINE/IMINIUM HALIDE, POLYHYDROXY CURING AGENT | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-05-31 | — | — | US | disclosed |
| EP-0103840-B1 | METHOD FOR PREPARING 1,2,3-TRIHETERO 5-MEMBERED HETEROCYCLIC COMPOUNDS | LEDERLE (JAPAN) LTD. (JP) | 1987-03-04 | — | — | EP | disclosed |
| EP-0182299-A2 | A curable fluoroelastomer composition | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1986-05-28 | — | — | EP | disclosed |
| US-4540794-A | Method for preparing 5-mercapto-1,2,3-thiadiazole salts | LEDERLE (JAPAN), LTD. (JP) | 1985-09-10 | — | — | US | disclosed |
| EP-0103840-A2 | Method for preparing 1,2,3-trihetero 5-membered heterocyclic compounds | LEDERLE (JAPAN) LTD. (JP) | 1984-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795144-B2 | Inhibitors of RAC1 and uses thereof for treating cancers | RAC1, KRAS, CYRIB | MAPT 4263/4885TSHR 2615/4885HSD17B10 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.